VANCOUVER, BC – Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement with an undisclosed publicly traded South Korean biopharmaceutical company,… Read More
VANCOUVER, B.C. – Miranda Lam has joined Acuitas Therapeutics as Chief Legal Officer & Sr. Director, Business Development, Acuitas President and CEO, Dr. Thomas Madden, announced recently. Ms. Lam comes… Read More
BURNABY, B.C. – Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments for epilepsy with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) achieved a regulatory… Read More
Mend the Gap researchers are collaborating on an innovative approach to SCI healing and recovery. BC – Researchers at the International Collaboration on Repair Discoveries (ICORD) are part of a… Read More
THOUSAND OAKS, CA & WALTHAM, MA – Amgen (NASDAQ:AMGN) and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against a range… Read More
